Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Hose

Showing results (91-100 of 189) with videos related to

Pageof 19
Sort By:
Plos One|January 4, 2014
The glycome of normal and malignant plasma cellsThomas M Moehler, Anja Seckinger, Dirk Hose, et al.
Blood|December 13, 2012
High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenanceAnnemiek Broyl, Rowan Kuiper, Mark van Duin, et al.
Frontiers in Cell and Developmental Biology|June 27, 2022
Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment ApproachPhilip Vlummens, Stefaan Verhulst, Kim De Veirman, et al.
Haematologica|March 12, 2010
Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantationKai Neben, Anna Jauch, Uta Bertsch, et al.
International Journal of Cancer|September 9, 2014
T cell-based targeted immunotherapies for patients with multiple myelomaLei Wang, Nan Jin, Anita Schmitt, et al.
Genes, Chromosomes & Cancer|July 8, 2005
Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogeneticsFriedrich W Cremer, Jelena Bila, Isabelle Buck, et al.
Blood Cancer Journal|September 5, 2023
Identification of NOTCH-driven matrisome-associated genes as prognostic indicators of multiple myeloma patient survivalDaniela Simone Maichl, Julius Arthur Kirner, Susanne Beck, et al.
British Journal of Haematology|June 5, 2007
Targeting NF-kappaB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growthMichel Jourdan, Jérôme Moreaux, John De Vos, et al.
European Radiology|July 29, 2015
Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI studyMaximilian Merz, Thomas M Moehler, Judith Ritsch, et al.
Cytometry. Part B, Clinical Cytometry|March 27, 2018
Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myelomaKatharina Kriegsmann, Tobias Dittrich, Brigitte Neuber, et al.
Pageof 19

Showing results (91-100 of 189) with videos related to

Sort By:
Pageof 19
Plos One|January 4, 2014
The glycome of normal and malignant plasma cellsThomas M Moehler, Anja Seckinger, Dirk Hose, et al.
Blood|December 13, 2012
High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenanceAnnemiek Broyl, Rowan Kuiper, Mark van Duin, et al.
Frontiers in Cell and Developmental Biology|June 27, 2022
Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment ApproachPhilip Vlummens, Stefaan Verhulst, Kim De Veirman, et al.
Haematologica|March 12, 2010
Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantationKai Neben, Anna Jauch, Uta Bertsch, et al.
International Journal of Cancer|September 9, 2014
T cell-based targeted immunotherapies for patients with multiple myelomaLei Wang, Nan Jin, Anita Schmitt, et al.
Genes, Chromosomes & Cancer|July 8, 2005
Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogeneticsFriedrich W Cremer, Jelena Bila, Isabelle Buck, et al.
Blood Cancer Journal|September 5, 2023
Identification of NOTCH-driven matrisome-associated genes as prognostic indicators of multiple myeloma patient survivalDaniela Simone Maichl, Julius Arthur Kirner, Susanne Beck, et al.
British Journal of Haematology|June 5, 2007
Targeting NF-kappaB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growthMichel Jourdan, Jérôme Moreaux, John De Vos, et al.
European Radiology|July 29, 2015
Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI studyMaximilian Merz, Thomas M Moehler, Judith Ritsch, et al.
Cytometry. Part B, Clinical Cytometry|March 27, 2018
Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myelomaKatharina Kriegsmann, Tobias Dittrich, Brigitte Neuber, et al.
Pageof 19